Latest Whitepapers
Whitepaper
Model Neurodegenerative Disease Traits More Closely
This whitepaper highlights how PFFs could become the breakthrough modeling platform for scientists to discover and develop the next therapeutic for neurodegenerative diseases.
Whitepaper
Select Better Antibodies Using NGS Data
This whitepaper explores the cutting-edge cloud-based antibody selection tools, that provide confident and timely antibody selection. It also highlights the latest analysis software for independent, intricate analyses and optimal antibody selection.
Whitepaper
Optimize Project Management in the DMTA Cycle
This whitepaper highlights how the latest software can help researchers overcome the uncertainties in drug discovery and enable efficient compound design, synthesis and progression tracking.
Whitepaper
Unlocking the Potential of Cancer Immunotherapy with 3D Immune Cell Killing Assays
This literature review explores the latest in 3D immune cell killing assays for cancer immunotherapy research.
Whitepaper
Spin It First: Solutions for Better Bioprocessing
High-intensity, high-volume cell cultures are an essential part of many bioproduction workflows – especially those operating at scale. However, aggregate accumulation, batch-to-batch cleaning and extensive sterility validation can all negatively impact overall workflow efficiency.
Whitepaper
Prep for Success With Quality Liquids and Buffers
The preparation of process liquids and buffers for in-house bioprocessing can be complex and face many logistical challenges. Additionally, a failure to optimize operational efficiency can result in supply chain disruption, total cost of ownership (TCO) and quality control challenges.
Whitepaper
Reducing Risk With Production Chemical and Sourcing Services
This case study highlights how a CDMO at risk of a facility shutdown solved severe supply disruption problems with the help of an experienced sourcing service.
Whitepaper
Antibody–Drug Conjugates: A Novel Paradigm for Cancer Therapy
This whitepaper highlights the key molecular components of ADCs and the challenges and opportunities for their future development.
Whitepaper
A Translational Perspective – Biacore Systems in Discovery and Early-Stage Development
For a smooth molecule journey from benchtop to clinic you need to make the most informed candidate selection and reduce the risk of failure and complications during development. Our BiacoreTM systems support informed decision-making during the lead candidate selection process. Its technology delivers valuable insights into developability such as manufacturability and safety.
Whitepaper
Combat Disruption in Gene Therapy Development
This whitepaper highlights common challenges in gene therapy development and explores the latest analytical approaches available to combat workflow disruption.
Advertisement
